Internal Medicine · Rowland Heights, CA
NPI
1669564811
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
18395 Colima Rd
Rowland Heights, CA, 91748
Phone (626) 964-1120
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,417 services
Medicare patients, 2024
166
Average age 76
Drug cost, 2024
$1.3M
6,148 prescriptions
Company payments, 2025
$1,865
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mary Wang was code 99213 (office e&m - established), 711 times for 155 patients. In total Mary Wang billed 1,417 services in 21 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 711 | 155 | $70.76 | $50K |
| 99497 Care Management/Coordination | Office | 94 | 94 | $82.65 | $7,769 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 93 | 93 | $140.30 | $13K |
| 36410 Vascular | Office | 91 | 59 | $14.28 | $1,300 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 87 | 87 | $26.81 | $2,332 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 87 | 87 | $21.09 | $1,835 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 86 | 86 | $21.09 | $1,814 |
| G0008 Administration of influenza virus vaccine | Office | 45 | 45 | $35.02 | $1,576 |
| 90658 Vaccine Product | Office | 44 | 44 | $21.42 | $942 |
| 36415 Venipuncture Blood Collection | Office | 39 | 36 | $8.65 | $337 |
| 99203 Office E&M - New | Office | 16 | 16 | $86.11 | $1,378 |
By year: 2022 $74K for 1,264 services; 2023 $78K for 1,319 services; 2024 $86K for 1,417 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 39 | 36 | $8.65 | $337 |
Medicare prescription drug claims, 2024
In 2024, the drug Mary Wang prescribed most often to Medicare patients was Atorvastatin Calcium, with 705 prescriptions and refills. In total Mary Wang wrote 6,148 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 705 | 1,868 | 224 | $6,872 |
| Amlodipine Besylate Generic | 439 | 1,118 | 123 | $2,945 |
| Losartan Potassium Generic | 370 | 949 | 106 | $5,040 |
| Metformin Hcl Generic | 310 | 766 | 82 | $2,754 |
| Alendronate Sodium Generic | 209 | 502 | 65 | $1,834 |
| Vascepa Icosapent Ethyl | 166 | 302 | 36 | $102K |
| Omeprazole Generic | 128 | 337 | 36 | $1,396 |
| Levothyroxine Sodium Generic | 122 | 347 | 33 | $1,821 |
| Tradjenta Linagliptin | 120 | 197 | 23 | $94K |
| Metoprolol Succinate Generic | 119 | 333 | 35 | $1,800 |
| Ezetimibe Generic | 119 | 303 | 40 | $2,623 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 116 | 147 | 36 | $3,969 |
| Tamsulosin Hcl Generic | 98 | 272 | 32 | $1,817 |
| Glimepiride Generic | 95 | 265 | 32 | $1,487 |
| Icosapent Ethyl Generic | 94 | 231 | 39 | $38K |
Brand drugs: 1,212 claims; generic drugs: 4,867 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mary Wang $1,865 ($1,865 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $1,199.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $1,199 |
| Abbvie Inc. ABBV | 7 | $224 |
| Aimmune Therapeutics, Inc. | 4 | $194 |
| Lilly USA, LLC LLY | 2 | $59.58 |
| Exact Sciences Corporation EXAS | 2 | $47.61 |
| Novo Nordisk Inc NVO | 2 | $46.25 |
| Amgen Inc. AMGN | 2 | $35.64 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $33.21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.